loading page

Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar.
  • +1
  • Almurtada Razok,
  • Abdullah Shams,
  • Ahmed Almeer,
  • Muhammad Zahid
Almurtada Razok
Hamad Medical Corporation

Corresponding Author:[email protected]

Author Profile
Abdullah Shams
Hamad Medical Corporation
Author Profile
Ahmed Almeer
Hamad Medical Corporation
Author Profile
Muhammad Zahid
Hamad Medical Corporation
Author Profile

Abstract

Guillain-Barré syndrome is an immune-mediated neuropathy that was reported following multiple vaccines. We present the case of a gentleman who developed GBS 20 days after the second dose of COVID-19 vaccination. It is important to mention that more research is needed to establish an association between COVID-19 vaccine and GBS.